Atricure, Inc. · NASDAQ:ATRC

Atricure — Fact Sheet (December 2025)

2 slides from Atricure's fact sheet, December 2025

1. Slide 1: Are you still in Afib?

   Are you still in Afib? Hybrid AF™ Therapy with EPi-Sense® coagulation device is a commercially available minimally invasive therapy to treat Advanced Afib.1 This procedure is unique as it treats both the inside and outside of your heart — unlike catheter ablation which only treats the inside. Hybrid

2. Slide 2: Hybrid AF Therapy References and Indications for Use

   Hybrid AF Therapy References 1. IFU for EPi-Sense® Guided Coagulation System Data: PMA# P200002 2. Delurgio, D.B. et al. (2020). Circ Arrhythm Electrophysiol, 13:e009288. DOI: 10.1161/CIRCEP.120.009288. 3. Gill, et al. (2023). Ann Cardiothorac Surg. https://www.annalscts.com/article/view/1705. EPi-S

AtriCure — Fact Sheet (December 2025) on 6ix